Bank of Nova Scotia Invests $126,000 in SIGA Technologies, Inc. (NASDAQ:SIGA)

Bank of Nova Scotia acquired a new stake in SIGA Technologies, Inc. (NASDAQ:SIGAGet Rating) during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm acquired 10,842 shares of the company’s stock, valued at approximately $126,000.

Other large investors have also bought and sold shares of the company. Los Angeles Capital Management LLC raised its position in SIGA Technologies by 13.9% in the first quarter. Los Angeles Capital Management LLC now owns 166,025 shares of the company’s stock valued at $1,177,000 after purchasing an additional 20,209 shares during the last quarter. Swiss National Bank grew its stake in SIGA Technologies by 6.1% during the first quarter. Swiss National Bank now owns 105,100 shares of the company’s stock worth $745,000 after purchasing an additional 6,000 shares during the period. Campbell & CO Investment Adviser LLC grew its stake in SIGA Technologies by 8.8% in the first quarter. Campbell & CO Investment Adviser LLC now owns 23,399 shares of the company’s stock valued at $166,000 after acquiring an additional 1,899 shares during the period. Aaron Wealth Advisors LLC acquired a new stake in SIGA Technologies in the first quarter valued at approximately $548,000. Finally, Bank of New York Mellon Corp boosted its position in shares of SIGA Technologies by 2.1% during the first quarter. Bank of New York Mellon Corp now owns 225,277 shares of the company’s stock valued at $1,598,000 after buying an additional 4,555 shares during the last quarter. 42.55% of the stock is owned by institutional investors and hedge funds.

SIGA Technologies Stock Up 0.1 %

Shares of NASDAQ:SIGA opened at $9.13 on Tuesday. The business’s 50 day moving average is $9.87 and its 200 day moving average is $12.69. The stock has a market cap of $666.71 million, a price-to-earnings ratio of 6.30 and a beta of 0.73. SIGA Technologies, Inc. has a 12-month low of $5.84 and a 12-month high of $26.99.

SIGA Technologies Profile

(Get Rating)

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats.

See Also

Want to see what other hedge funds are holding SIGA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SIGA Technologies, Inc. (NASDAQ:SIGAGet Rating).

Institutional Ownership by Quarter for SIGA Technologies (NASDAQ:SIGA)

Receive News & Ratings for SIGA Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SIGA Technologies and related companies with MarketBeat.com's FREE daily email newsletter.